Conference Abstracts

  1. Topcu C., Georgiou V., Hezka Rodosthenous J., Foley B.T. and Kostrikis L.G. Identification of a New HIV-1 Circulating Recombinant Form CRF91_cpx in Cyprus. 20th European Meeting on HIV & Hepatitis. Paris, France, 2022
  2. Topcu C., Chrysostomou A.C., Georgiou V., Hezka Rodosthenous J. and Kostrikis L.G. HIV-1 Molecular Phylogenies Characterized by Near Full-Length Genome Sequencing. 20th European Meeting on HIV & Hepatitis. Paris, France, 2022
  3. Topcu C., Georgiou V., Hezka Rodosthenous J., Demetriades and Kostrikis L.G. Independent Epidemic Patterns of HIV-1 Driven by Young Cypriot MSM in Cyprus. 24th International AIDS Conference. Montreal, Canada, 2022
  4. Topcu C., Georgiou V., Hezka Rodosthenous J., Foley B.T. and Kostrikis L.G. Identification of a New HIV-1 Circulating Recombinant Form CRF91_cpx among Men Who Have Sex with Men in Cyprus. 24th International AIDS Conference. Montreal, Canada, 2022
  5. Topcu C., Chrysostomou C.A., Johana Hezka Rodosthenous J., Georgiou V., Stathi G., Demetriades I. and Kostrikis L.G. Molecular Epidemiology Analysis Reveals Actively Growing Transmission Clusters in the Polyphyletic HIV-1 Infection in Cyprus (2019-2020). 19th European Meeting on HIV & Hepatitis. Virtual Conference, 2021
  6. Chrysostomou A.C., Vracken B., Koumbaris G., Themistokleous G., Aristokleous A., Masia C., Eleftheriou C., Iοannou C., Stylianou D., Ioannides M., Petrou P., Georgiou V., Hatziyianni A., Lemey P., Vandamme A.-M., Patsalis P.P. and Kostrikis L.G. A Comprehensive Molecular Epidemiological Analysis of SARS-CoV-2 infection in Cyprus from April 2020 to January 2021: Evidence of a Highly Polyphyletic and Evolving Epidemic. 19th European Meeting on HIV & Hepatitis. Virtual Conference, 2021
  7. Chrysostomou A.C., Vracken B., Koumbaris G., Themistokleous G., Aristokleous A., Masia C., Eleftheriou C., Iοannou C., Stylianou D., Ioannides M., Petrou P., Georgiou V., Hatziyianni A., Lemey P., Vandamme A.-M., Patsalis P.P. and Kostrikis L.G. A SARS-Cov-2 B Variant (B.1.258) Has Emerged and Is Dominating the Current Cyprus Epidemic. 19th European Meeting on HIV & Hepatitis. Virtual Conference, 2021
  8. Chrysostomou A.C., Hezka Rodosthenous J., Topcu C., Papa C., Aristokleous A., Eleftheriou C. and Kostrikis L.G. A Multi-Allelic Molecular-Beacon-Based Real-Time RT-PCR Assay for the Detection of the Coronavirus SARS-CoV-2 from Clinical Samples. 19th European Meeting on HIV & Hepatitis. Virtual Conference, 2021
  9. Quattrocchi1 A., Mamais I., Tsioutis C., Christaki E., Constantinou C., Koliou M., Pana Z.D., Silvestros V., Theophanous F., Charalambous C., Stylianou A., Sotiriou S., Athanasiadou M., Kyprianou T., Demetriou A., Demetriou A.C., Kolokotroni O., Gregoriou I., Pafitou N., Panos G., Kostrikis L.G., Karayiannis P., Petrikkos G., Agathaggelou P., Mixidis G., Siakallis G., Hadjihannas L., Palazis L., Vavlitou A., Matsentidou-Timilliotou H.,  Koukios D., Adamidi T., Frangopoulos F., Constantinou E., Nikolopoulos G. Low Secondary Attack Rate of COVID-19 in the Republic of Cyprus from a Nationwide Contact-Tracing Strategy During March-May 2020. European Scientific Conference on Applied Infectious Disease Epidemiology. Online Event, 2020
  10. Tsioutis C., Christaki E., Quattrocchi A., Mamais I., Constantinou C., Koliou M., Pana Z.D., Silvestros V., Theophanous F., Charalambous C., Stylianou A., Sotiriou S., Athanasiadou M., Kyprianou T., Demetriou A., Demetriou A.C., Kolokotroni O., Gregoriou I., Pafitou N., Panos G., Kostrikis L.G., Karayiannis P., Petrikkos G., Agathaggelou P., Siakallis G., Hadjihannas L., Palazis L., Vavlitou A., Matsentidou-Timilliotou H.,  Koukios D., Adamidi T., Frangopoulos F., Mixides G., Constantinou E., Nikolopoulos G. Detection of SARS-CoV-2 in Healthcare Workers in the Republic of Cyprus. ESCMID Conference on Corona Virus Disease. Virtual Conference, 2020
  11. Christaki E., Tsioutis C., Quattrocchi A., Mamais I., Constantinou C., Koliou M., Pana Z.D., Silvestros V., Theophanous F., Charalambous C., Stylianou A., Sotiriou S., Athanasiadou M., Kyprianou T., Demetriou A., Demetriou A.C., Kolokotroni O., Gregoriou I., Pafitou N., Panos G., Kostrikis L.G., Karayiannis P., Petrikkos G., Agathaggelou P., Mixides G., Siakallis G., Hadjihannas L., Palazis L., Vavlitou A., Matsentidou-Timilliotou H.,  Koukios D., Adamidi T., Frangopoulos F., Constantinou E., Nikolopoulos G. Clinical and Epidemiological Characteristics of COVID-19 Patients in the Republic of Cyprus. ESCMID Conference on Corona Virus Disease. Virtual Conference, 2020
  12. Kostrikis L.G., Chrysostomou A., Topcu C., Stylianou D. and Hezka J. A new comprehensive HIV-1 genotypic drug resistance assay for all commercially available reverse transcriptase, protease and integrase inhibitors in patients infected with group M HIV-1 strains. 23rd International AIDS Conference. San Francisco, U.S., 2020.
  13. Chrysostomou A., Topcu C., Cinarli P., Stylianou D., Hezka Rodosthenous J., Demetriades I. and Kostrikis L.G. Molecular Epidemiology of the HIV-1 Infection in Cyprus (2017-2019): A Polyphyletic Infection with an Increasing Prevalence of Drug Resistance. 18th European Meeting on HIV & Hepatitis. Virtual Conference, 2020.
  14. Paraskevis D., Stylianou D.C., Hezka J., Stern Z., Oikonomopoulou M., Mamais I., and Kostrikis L.G. HCV Phylogeography of the General Population and High-Risk Groups in Cyprus Identifies the Island as a Global Sink for and Source of Infection. 2nd Conference on Liver Disease in Africa. Cairo, Egypt, 2019.
  15. Shiakallis G., Kasapis C., Kostrikis L.G., Pieridou D. and Demetriades I. Pregnancy Outcomes of HIV-Positive Women: A Retrospective National Cohort Study from the “Grigorios AIDS Clinic” in Cyprus. Infectious Diseases Week 2019. Washington, D.C., USA, 2019.
  16. Chrysostomou A.C., Topcu C., Stylianou D.C., Demetriades I. and Kostrikis L.G. Near Real-Time Monitoring of HIV-1 Transmission Hotspots in Cyprus from Phylogenetics: The Cyprus HIV-1 Transmission Cohort Study (CHICS). Infectious Diseases Week 2019. Washington, D.C., USA, 2019.
  17. Seguin-Devaux C., Hofstra M.L., Hunewald O., Alexiev I., Bobkova M., Descamps D., Griskevicius A., de Jong D.M.C., Kostrikis L.G., Lambert C., Liitsola K., Mor O., Paraskevis D., Parczewski M., Poljak M., Ruelle J., Servais J-Y., Zidovec Lepej S., Nijhuis M., Wensing A.M.J., Boucher C.A.B. on behalf of the SPREAD Program. European Surveillance of HIV Drug Resistance to NRTI, NNRTI and INSTI in Newly Diagnosed Individuals Using Next-Generation Sequencing. 17th European Meeting on HIV & Hepatitis. Rome, Italy, 2019.
  18. Chrysostomou A., Topcu C., Stylianou D., Ioannou M., Ioannou L., Hezka J., Demetriades I., and Kostrikis L.G. A Touchdown PCR Assay of HIV-1 Pol for a Comprehensive Genotypic Drug Resistance Analysis of Patients Infected with Group M HIV-1 strains. 17th European Meeting on HIV & Hepatitis. Rome, Italy, 2019.
  19. Kostrikis L.G. Phage-Display Systems for Development of Novel Vaccines. International Conference on Immunology and Vaccination. Rome, Italy 2019.
  20. Kostrikis L.G. Longitudinal HIV-1 Phylogenetic and Phylodynamic Transmission Analyses in Cyprus: The Cypriot HIV-1 Transmission Cohort Study (CHICS). PCS 4th Annual Health Care Congress-2019. Marrakech, Morocco, 2019.
  21. Kostaki E., Stylianou D.C., Mavrikaki S., Hexka J., Chrysostomou A., Demetriades I., Paraskevis D. and Kostrikis L. G. Phylogeographic Analysis of HIV-1 Subtype A Infection in Cyprus: The Cyprus HIV-1 Transmission Cohort Study (CHICS) from 1986 to 2012. 16th European Meeting on HIV & Hepatitis. Rome, Italy, 2018.
  22. Marshall A.D., Cunningham E.B., Nielsen S., Aghemo A., Alho H., Backmund M., Bruggmann P., Dalgard O., Seguin-Devaux C., Flisiak R. Foster G.R., Gheorghe L., Goldberg D., Goulis I., Hickman M., Hoffmann P., Jancorienė L., Jarcuska P., Kåberg M., Kostrikis L.G., Makara M., Maimets M.22, Marinho R.T., Matičič M., Norris S., Ólafsson S., Øvrehus A., Pawlotsky J.M., Pocock J., Robaeys G., Roncero C., Simonova M., Sperl J., Tait M., Tolmane I., Tomaselli S., van der Valk M., Vince A., Dore G.J., Lazarus J.V., Grebely J., International Network on Hepatitis in Substance Users (INHSU). Restrictions for Reimbursement of Interferon-Free Direct-Acting Antiviral Therapies for HCV Infection in Europe. Canadian Liver Meeting. Toronto, Canada, 2018
  23. Demetriades I. and Kostrikis L.G. Monitoring of HIV-1 Drug Resistance Mutations in Newly Diagnosed Patients in Cyprus (2010-2012). Infectious Diseases Week 2017. San Diego, CA, USA, 2017
  24. Kostrikis L. G. HIV Disease: From Biology to Chemotherapeutics and Beyond. 5th International Bio-Medical Scientific Cyprus Congress. Nicosia, Cyprus, 2017.
  25. Hezka J., Stylianou D., Kostaki E.G., Andreou M., Kousiappa I., Demetriades I. and Kostrikis L.G. Molecular Epidemiology of Newly Diagnosed HIV-1 Infected Patients in Cyprus (2010-2012) Reveals Active Transmission Networks Among Young Men Having Sex with Men and Low Transmitted Drug Resistance. 15th European Meeting on HIV & Hepatitis. Rome, Italy, 2017.
  26. Hofstra L.M., Sauvageot N., Albert J., Alexiev I., Struck D., Van de Vijver D.A.M.C., Åsjö B., Beshkov D., Coughlan S., Descamps D., Garcia F., Gomes P., Griskevicius A., Hamouda O., Horban A., Kolupajeva T., Kostrikis L.G., Liitsola K., Linka M., Mor O., Nielsen C., Otelea D., Paraskevis D., Parczewski M., Paredes R., Poljak M., Puchhammer-Stöckl E., Ruelle J., Sönnerborg A., Staneková D., Stanojevic M., Van Laethem K., Yalcinkaya T., Zazzi M., Zidovec Lepej S., Schmit J-C., Boucher C.A.B. and Wensing A.M.J. on behalf of the SPREAD program Interactive Monitoring of HIV Drug Resistance Mutations in Newly Diagnosed Patients in Europe. 27th European Congress of Clinical Microbiology and Infectious Diseases. Vienna, Austria, 2017
  27. Kostrikis L. G. Development of Vaccines Using Genetically Engineered Inoviruses. 16th International Conference on Vaccines. Berlin, Germany, 2017
  28. Kostrikis L. G. Next-Generation Approaches to Designing HIV-1 Vaccines. 12th Global Vaccines and Vaccination Summit. Dubai, UAE, 2016
  29. Kostrikis L. G. Engineering Antigen-Displayed Phage as Vaccines. 4th World Congress on Targeting Infectious Diseases. Paris, France, 2016
  30. Oikonomopoulou M., Demetriou V., Kostrikis L. G. And Paraskevis D. Re-Analysis of Unassigned Hepatitis C Virus (HCV) Strain CYHCV025: Evidence of a Highly Divergent Lineage within Genotype 1. International Symposium HIV & Emerging Infectious Diseases (ISHEID) 2016 Congress. Marseille, France, 2016
  31. Pineda-Peña A-C, Theys K., Hezka J., Kousiappa I., Andreou M., Demetriades I.4, Abecasis A. B. and Kostrikis L. G. Molecular Epidemiology of HIV-1 Infection in Cyprus: Onward Transmission is Predominantly Driven by Young Adults. International Symposium HIV & Emerging Infectious Diseases (ISHEID) 2016 Congress. Marseille, France, 2016
  32. Paraskevis D., Demetriou V., Oikonomopoulou M., Mamais I., Hezka J., Andoniadou M., Andreou I., Stylianou D. C., and Kostrikis, L. G. A Phylogeographic Analysis of HCV Viral Sequences from the General Population and High-Risk Groups Including Intravenous Drug Users Attending Therapy Programs in Cyprus. 14th European Meeting on HIV & Hepatitis. Rome, Italy, 2016.
  33. Pineda-Peña A-C., Theys K., Hezka J., Kousiappa I., Andreou M., Demetriades I., Stylianou D.C., Abecasis A.B., Kostrikis L.G. and on the behalf of the SPREAD Program of ESAR. Transmission Patterns of Concurrent HIV-1 Subtype Epidemics Circulating in Cyprus: A Phylodynamic Analysis. 14th European Meeting on HIV & Hepatitis. Rome, Italy, 2016.
  34. Kostaki E., Flampouris A., Angelis K., Mamais I., Albert J., AltzerinakouM. A., Lawyer G., Hamouda O., Struck D., Vercauteren J., Wensing A-M., Alexiev I., Åsjö B., Balotta C, Camacho R.J., Coughlan S., Doulis I., Griskevicius A., Grossman Z., Hatzakis A., Horban A., Kikeri M., Kostrikis L.G., Lepej S. J., Liitsola K., Linka M., Markozanes G., Magiorkinis G., Nielsen C., Otelea D., Paredes R., Poljak M., Puchhammer-Stöckl E., Schmit J-C.,  Sönnerborg A., Staneková D., Stanojevic M., Boucher C. A. B. on behalf of the SPREAD program, Nikolopoulos G., Vasylyeva T., Friedman S. R., van de Vijver D.A.M.C., Angarano G., Chaix M-L., de Luca A., Korn K., Loveday C., Soriano V., Yerly S., Zazzi M., Vandamme A-M. And Paraskevis D. Dating Regional Subtype B Subepidemics: Evidence for Earliest Introduction in Western Europe and Caribbean. 14th European Meeting on HIV & Hepatitis. Rome, Italy, 2016.
  35. Hofstra L. M., Sauvageot N., Albert J., Alexiev I., Struck S., Van de Vijver D.A.M.C., Åsjö B., Beshkov D., Coughlan S., Descamps D., Garcia F., Gomes P., Griskevicius A., Hamouda O., Horban A., Kolupajeva T., Kostrikis L.G., Liitsola K., Linka M., Mor O., Nielsen C., Otelea D., Paraskevis D., Parczewski M., Paredes R., Poljak M., Puchhammer-Stöckl E., Ruelle J., Sönnerborg A., Staneková D., Stanojevic M., Van Laethem K., Yalcinkaya T., Zazzi M., Zidovec Lepej S., Schmit J-C., Boucher C.A.B. and Wensing A.M.J on behalf of the SPREAD Program. Transmission of HIV Resistance Mutations Varies Regionally in Europe. 14th European Meeting on HIV & Hepatitis. Rome, Italy, 2016.
  36. Hofstra L. M., Geretti A. M., Boucher C. A. B., De Luca A., Descamps D., Harrigan P. R., Schmit J. C.,  Vandekerckhove L., Wensing A. M. J. on behalf of the European Guidance Group on Clinical Management of HIV-1 Low Level Viremia. Consensus Guidance on Clinical Management of Low-Level Plasma HIV-1 RNA Rebound after Initial Suppression. 15th European AIDS Conference (European AIDS Clinical Society, EACS). Barcelona, Spain, 2015
  37. Hofstra L.M., Sauvageot N., Albert  J., Alexiev I., Struck D., Van de Vijver D.6, Åsjö B., Beshkov D., Camacho R., Coughlan S.,Descamps D., Garcia F., Griskevicius A., Hamouda O., Horban A., Kolupajeva T., Kostrikis L. G., Liitsola K., Linka M., Mor O., Nielsen C., Otelea D., Paraskevis D., Parczewski M., Paredes R., Poljak M., Puchhammer-Stöckl E., Ruelle J., Sönnerborg A., Staneková D., Stanojevic M., Vandamme A., Yalcinkaya T., Zazzi M., Zidovec Lepej S., Schmit J-C., Boucher C. A. B. and Wensing A. M. J. on behalf of the SPREAD Program. Regional Differences in Transmission of HIV Drug Resistance Mutations in Europe. 15th European AIDS Conference (European AIDS Clinical Society, EACS). Barcelona, Spain, 2015
  38. Kostrikis L. G. Novel Vaccines Utilizing Antigen-Displayed Inoviral Vectors. 7th Global Summit on Vaccines and Vaccination. Dubai, UAE, 2015
  39. Mamais I., Albert J., Angelis K., Magiorkinis G., Beloukas A., Hatzakis A., Hamouda O., Struck D., Vercauteren J., Wensing A.M.J., Alexiev I., Åsjö B., Balotta C., Camacho R.J., Coughlan S., Griskevicius A., Grossman Z., Horban A., Kostrikis L.G., Lepej S., Liitsola K., Linka M., Nielsen C., Otelea D., Paredes R., Poljak M., Puchhammer-Stöckl E., Schmit J.C., Sönnerborg A., Staneková D., Stanojevic M., Boucher C. A. B., the SPREAD programme, Vandamme A-M. and Paraskevis D. The Global Spread of HIV-1 Subtype A Epidemic: A Phylogeographic Analysis. 13th European Meeting on HIV & Hepatitis –Treatment Strategies & Antiviral Drug Resistance. Barcelona, Spain, 2015
  40. Hofstra L. M., Boucher C. A. B., Descamps D., Geretti A. M., Harrigan P. R., Vandekerckhove L., Wensing A. M. J. on behalf of the European Guidance Group on clinical management of HIV-1 low level viremia. European Guidance on Clinical Management of HIV Low Level Viremia. 13th European Meeting on HIV & Hepatitis –Treatment Strategies & Antiviral Drug Resistance. Barcelona, Spain, 2015
  41. Magiorkinis G., Angelis K., Mamais I., Katzourakis A., Hatzakis A., Albert J., Lawyer G.,  Hamouda O., Struck D., Vercauteren J., Wensing A.M.J., Alexiev I., Åsjö B., Balotta C., Camacho R.J., Coughlan S., Griskevicius A., Grossman Z., Horban A., Kostrikis L.G., Liitsola K., Linka M., Nielsen C., Otelea D., Paredes R., Poljak M., Puchhammer-Stöckl E., Schmit J.C., Sönnerborg A., Staneková D., Stanojevic M. and Boucher C.A.B., Nikolopoulos G., Friedman S.R., Vandamme A-M. and Paraskevis D. Geopolitical Effects in the Epidemiology of HIV-1 Subtype B. 2015 Conference on Retroviruses and Opportunistic Infecetions (CROI). Seattle, USA, 2015
  42. Kostrikis L. G. HIV-1 Neutralizing Epitopes Displayed on the Surface of Inoviruses as Vaccine Immunogens to Raise Antiviral Antibody Responses. International Symposium HIV & Emerging Infectious Diseases (ISHEID) 2014 Congress. Marseille, France, 2014
  43. Mamais I., Albert J., Magiorkinis G., Hatzakis A., Hamouda O., Struck D., Vercauteren J., Wensing A. M. J., Alexiev I., Asjo B., Balotta C., Camacho R. J. Coughlan S., Griskevicius A., Grossman Z., Horban A., Kostrikis L. G., Lepej S., Liitsola K., Linka M., Nielsen C., Otelea D., Paredes R., Poljak M., Puchhammer-Stockl E., Schmit J. C., Sonnerborg A., Stranekova D., Stranojevic M., Boucher C. A. B. On behalf of the SPREAD program, Vandamme A-M. And Paraskevis D. The Global Spread of HIV-1 CRF_AE Epidemic: A Phylogeographic Analysis. 20th International AIDS Conference. Melbourne, Australia, 2014
  44. Magiorkinis G., Angelis K., Mamais I., Katzourakis A., Hatzakis A., Albert J., Lawyer G., Hamouda O., Struck D., Vercauteren J., Wensing A.M.J., Alexiev I., Åsjö B., Balotta C., Camacho R.J., Coughlan S., Griskevicius A., Grossman Z., Horban A., Kostrikis L.G., Liitsola K., Linka M., Nielsen C., Otelea D., Paredes R., Poljak M., Puchhammer-Stöckl E., Schmit J.C., Sönnerborg A., Staneková D., Stanojevic M. and Boucher C.A.B. on behalf of the SPREAD program, Nikolopoulos G., Friedman S.R., Vandamme A-M. and  Paraskevis D. The Geopolitical Evolution of HIV-1 Subtype B Epidemic Epidemic. 20th International AIDS Conference. Melbourne, Australia, 2014
  45. Hofstra L.M., Sauvageot N., Albert J., Alexiev I., Garcia F., Struck D., van de Vijver D., Åsjö B., Balotta C., Beshkov D., Camacho R.J., Coughlan S., Griskevicius A., Hamouda O., Horban A.,  Kolupajeva T., Kostrikis L.G., Kücherer C., Liitsola K., Linka M., Mor O., Nielsen C., Otelea D.,  Paraskevis D., Paredes R., Parruti G., Poljak M., Puchhammer-Stöckl E., Sönnerborg A.,  Staneková D., Stanojevic M., Vandamme A-M., Zidovec Lepe S., Boucher C.A.B., Schmit J.C. and Wensing A.M.J. on behalf of the SPREAD program. Prevalence of Resistance Mutations Associated with Decreased Susceptibility to Rilpivirine in Antiretroviral Naive Patients from Europe.  12th European Meeting on HIV & Hepatitis –Treatment Strategies & Antiviral Drug Resistance. Barcelona, Spain, 2014
  46. Casadellà M., Ham P.M., van Kessel A., Noguera-Julian M., Pou C., Garcia F., Struck D., Alexiev I., Åsjö B., Kostrikis L.G., Kücherer C., Liitsola K., Linka M., Nielsen C., Otelea D., Paraskevis D., Poljak M., Puchhammer-Stöckl E., Staneková D., Stanojevic M., Vandamme A-M., Zidovec Lepej S., Clotet B., Boucher C., Paredes R. and Wensing A.M. on behalf of the SPREAD programme. Primary Resistance to Integrase Strand-Transfer Inhibitors in Europe. 12th European Meeting on HIV & Hepatitis –Treatment Strategies & Antiviral Drug Resistance. Barcelona, Spain, 2014
  47. Kostrikis L.G., van de Vijver D. and Kousiappa I. HIV-1 Dissemination in Cyprus, the Eastern European Frontier: Phylogeographic and Temporal Dynamic Analyses of Viral Sequences Nearly a Decade. 12th European Meeting on HIV & Hepatitis –Treatment Strategies & Antiviral Drug Resistance. Barcelona, Spain, 2014
  48. Pineda-Peña A-C., Schrooten Y., Vinken L., Ferreira F., Li G. , Sequeira Trovão N., Khouri R., Derdelinckx I., de Munter P., Kücherer C., Kostrikis L.G., Nielsen C., Liitsola K., Balotta C., Wensing A.M.J., Stanojevic M., Paredes R., Albert J., Boucher C.A.B., Gomez-Lopez A., van Wijngaerden E., van Ranst M., Vercauteren J., van Laethem K. and  Vandamme A-M. Predictors of HIV-1 Transmitted Drug Resistance and Transmission Networks in the Leuven Cohort. 12th European Meeting on HIV & Hepatitis –Treatment Strategies & Antiviral Drug Resistance. Barcelona, Spain, 2014
  49. Hofstra L. M., D. Pilalas D., Alexiev I., F. Garcia F., Hamouda O., Staneková D.,  Struck D., Albert J., Åsjö B., Balotta C., Beshkov D., Camacho R. J, Coughlan S.,  Griskevicius A., Horban A., Kostrikis L. G., Kücherer C., Liitsola K., Linka M.,  Mor O., Nielsen C., Otelea D., Paraskevis D., Paredes R., Poljak M., Puchhammer-Stöckl E., Stanojevic M., Vandamme A-M, Zidovec Lepej S, Boucher C. A. B., Wensing A. M. J. and Schmit J. C. on behalf of the SPREAD program. Migrants Have a Higher Risk of Presenting in an Advanced Stage of HIV Infection Compared to Natives, Particularly Heterosexual and non-European Migrants.  5th European Conference on Migrant and Ethnic Minority and Healthcare. Granada, Spain, 2014
  50. Casadella M., Ham P. M., Noguera-Julian M., Struck D., Clotet B., Boucher C. A. B., Paredes R., Wensing A. M. J. on behalf of the SPREAD program. Primary Resistance to Integrase Strand Inhibitors in Europe.  2014 Conference on Retroviruses and Opportunistic Infecetions (CROI). Boston, USA, 2014
  51. Hofstra L. M., D. Pilalas D., Alexiev I., F. Garcia F., Hamouda O., Staneková D.,  Struck D., Albert J., Åsjö B., Balotta C., Beshkov D., Camacho R. J, Coughlan S.,  Griskevicius A., Horban A., Kostrikis L. G., Kücherer C., Liitsola K., Linka M.,  Mor O., Nielsen C., Otelea D., Paraskevis D., Paredes R., Poljak M., Puchhammer-Stöckl E., Stanojevic M., Vandamme A-M, Zidovec Lepej S, Boucher C. A. B., Wensing A. M. J. and Schmit J. C. on behalf of the SPREAD program. Europe-wide Increase of Early Detection of HIV-1 MSM, but Additional Strategies Are Needed for Other Risk Groups.  14th European AIDS Clinical Society (EACS) Conference. Brussels, Belgium, 2013
  52. Hofstra L. M., Sauvageot N., Albert J., Alexiev I., Garcia F., Struck D., Vercauteren J., Van de Vijver D., Åsjö B., Balotta C., Beshkov D., Camacho R. J., Coughlan S., Griskevicius A., Hamouda O., Horban A., Kolupajeva T., Kostrikis L. G., Kücherer C., Liitsola K., Linka M., Mor O., Nielsen C., Otelea D., Paraskevis D., Paredes R., Poljak M., Puchhammer-Stöckl E., Sönnerborg A., Staneková D., Stanojevic M., Vandamme A-M., Zidovec Lepej S., Boucher C. A. B., Schmit J. C. And Wensing A. M. J. on behalf of the SPREAD program. The Burden of Transmitted Drug Resistance in Clinical Practice in Europe is Increasing over Time Despite a Stable Prevalence. 8th International Workshop on HIV Transmision. Barcelona, Spain, 2013
  53. Hofstra L. M., Sauvageot N., Albert J., Alexiev I., Garcia F., Struck D., Vercauteren J., Van de Vijver D., Åsjö B., Balotta C., Beshkov D., Camacho R. J., Coughlan S., Griskevicius A., Hamouda O., Horban A., Kolupajeva T., Kostrikis L. G., Kücherer C., Liitsola K., Linka M., Mor O., Nielsen C., Otelea D., Paraskevis D., Paredes R., Poljak M., Puchhammer-Stöckl E., Sönnerborg A., Staneková D., Stanojevic M., Vandamme A-M., Zidovec Lepej S., Boucher C. A. B., Schmit J. C. And Wensing A. M. J. on behalf of the SPREAD program. Increasing Number of HIV-1 Diagnoses with Transmitted Drug Resistance across Europe Despite Stable Prevalence. 14th European AIDS Clinical Society (EACS) Conference. Brussels, Belgium, 2013
  54. Antoniadou Z., Kousiappa I., Mamais I., Hezka J., Pilalas D., Skoura L., Metallidis S., Nikolaidis P., Malisiovas N. and Kostrikis L. G. Genetic Characterization of HIV-1 Strains and Cellular HIV-1 DNA Quantification from Newly Diagnosed Antiretroviral Naive Individuals in Northern Greece: Evidence of High Prevalence of Transmitted Drug Resistance Among MSM. 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention. Kuala-Lumpur, Malaysia, 2013
  55. Kousiappa I., Hezka J., Andreou M., Demetriades I. and Kostrikis L. G. The Molecular Epidemiology of HIV-1 Infection in Cyprus from 2010 to 2012 Revealed an Ongoing Influx of Different HIV-1 Lineages and Low Transmitted Drug Resistance Among Antiretroviral Naive Infected Individuals. 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention. Kuala-Lumpur, Malaysia, 2013
  56. Antoniadou Z., Kousiappa I., Mamais I., Hezka J., Pilalas D., Skoura L., Metallidis S., Nikolaidis P., Malisiovas N. and Kostrikis L. G. Genetic Characterization of HIV-1 Strains and Cellular HIV-1 DNA Quantification of Newly Diagnosed Antiretroviral Naive Patients in Northern Greece. 11th European Meeting on HIV and Hepatitis Workshop. Rome, Italy 2013
  57. Kousiappa I., Hezka J., Demetriades I. and Kostrikis L. G. Ongoing Influx of Different HIV-1 Lineages and Low Transmitted Drug Resistance Among Antiretroviral Naive Infected Individuals in Cyprus (2010-2012). 11th European Meeting on HIV and Hepatitis Workshop. Rome, Italy 2013
  58. Iacovides D., Hezka J., Savvopoulou N., Chrysanthou A. and Kostrikis L. G. Molecular Epidemiology and Genetic Analysis of HCV Infection in Cyprus within an Intravenous Drug User Study Cohort . 17th  International Symposium on HIV and Emerging Infectious Diseases. Marseille, France, 2012
  59. Antoniadou Z., Kousiappa I., Hezka J., Skoura L., Metallidis S., Nicolaidis P., Malisiovas N. And Kostrikis L. G. Molecular Epidemiology and Drug Resistance Prevalence of Strains from Newly-Diagnosed HIV-1 Patients in Northern Greece. 17th  International Symposium on HIV and Emerging Infectious Diseases. Marseille, France, 2012
  60. Iacovides D., Hezka J., Savvopoulou N., Chrysanthou A. and Kostrikis L. G. Genetic Studies of HCV Isolates from Intravenous Drug Users in Cyprus. 10th European Meeting on HIV and Hepatitis. Barcelona, Spain, 2012
  61. Kousiappa I., Lazarou Y., Othonos K. M. and Kostrikis L. G. Influx of Uncommon HIV-1 Strains from Eastern Europe and Identification of a New Unique Recombinant Strain Among Young Cypriot MSM in Cyprus. 17th  International Symposium on HIV and Emerging Infectious Diseases. Marseille, France, 2012
  62. Frentz D., van de Vijver D.A.M.C., Abecasis A., Albert J., Bruun Jørgensen L., Hamouda O., Kücherer C., Schmit J.-C., Struck D., Vandamme A.-M., Vercauteren J., Åsjö B., Balotta C., Beshkov D., Camacho R., Coughlan S., Griskevicius A., Grossman, A. Horban, T. Kolupajeva, K. Korn, L. Kostrikis, K. Liitsola, M. Linka, D. Otelea Z., Paraskevis D., Paredes R., Poljak M., Puchhammer-Stöckl E., Schuurman R., Sönnerborg A., Staneková D., Stanojevic M., Zidovec Lepej S., Wensing A.M.J., Boucher C.A.B., on behalf of the SPREAD programme. Transmission of HIV Resistance to Non-Nucleoside RT Inhibitors is Rising in Europe. 13th European AIDS Conference. Belgrade, Serbia, 2011
  63. Vandekerckhove L. P. R. , Wensing A. M. J. , Kaiser R., Brun-Vézinet F., Clotet B., De Luca A., Dressler S., Garcia F., Geretti A. M., Klimkait T., Korn K., Masquelier B., Perno C. F., Schapiro J. M., Soriano V., Sönnerborg A. M., Vandamme A. M., Verhofstede C., Walter H., Zazzi M. andBoucher C. A. B. on behalf of the European Consensus Group on Clinical Management of Tropism Testing. Consensus Statement of the European Guidelines on Clinical Management of HIV-1 Tropism Testing vs 1.0. 9th European Workshop on HIV & Hepatitis -Treatment Strategies & Antiviral Drug Resistance. Pafos, Cyprus, 2011
  64. Demetriou V. L., Kyriakou E., Chimonides S., Evgeniou A., Hadjigeorgiou-Vounou E., Hadjivasileiou E., Koliou-Mazeri M., Papakyriakou P., Petsas L., Potamitis G. And Kostrikis L. G. 9th European Workshop on HIV & Hepatitis -Treatment Strategies & Antiviral Drug Resistance. Pafos, Cyprus, 2011
  65. Kousiappa I., Achilleos C., Hezka J., Othonos K., Demetriades I. And Kostrikis L. G. Continued Influx of Different Lineages of HIV-1 Virus in Cyprus: A 3-Year Molecular Epidemiology Study 2007 – 2009. 9th European Workshop on HIV & Hepatitis -Treatment Strategies & Antiviral Drug Resistance.Pafos, Cyprus, 2011
  66. Frentz D., on behalf of the SPREAD Programme of the EuropeHIVResistance Network. Recent Dynamics of Transmitted Drug Resistance in Europe: SPREAD Program 2006 – 2007. 9th European Workshop on HIV & Hepatitis -Treatment Strategies & Antiviral Drug Resistance. Pafos, Cyprus, 2011
  67. Abecasis A. B.,Wensing A. M. J., Vercauteren J., Paraskevis D., Vijver D., Theys K., Albert J., Schmit J-C., Kücherer C., Hamouda O., Struck D., Åsjö B., Balotta C., Bruun Jørgensen L., Camacho R., Coughlan S., Grossman Z., Horban A., Kostrikis L. G., Liitsola K., Linka M., Paredes R., Poljak M., Puchhammer-Stöckl E., Sönnerborg A., Stanekova D., Stanojevic M., Boucher C. and Vandamme A-M. on behalf of the SPREAD Programme of the European Society for Antiviral Resistance and the EuropeHIVResistance Network. Genetic Diversity of HIV-1 in Europe and its Demographic Determinants (2002 – 2005). 9th European Workshop on HIV & Hepatitis -Treatment Strategies & Antiviral Drug Resistance. Paphos, Cyprus, 2011
  68. Achilleos C., Kousiappa I. and Kostrikis L. G. Genetic Characterization of Near-Full Length HIV-1 Sequences Derived from Sub-Sahara Africa in Cyprus. 5th Congress of Clinical Chemistry and Laboratory Medicine. Limassol, Cyprus, 20111
  69. Kyriakou E., Demetriou V. L. And Kostrikis L. G. Optimization of a Protocol for Near-Full Characterization of Two Putative Hepatitis C Virus 2k/1b Recombinants. 5th Congress of Clinical Chemistry and Laboratory Medicine. Limassol, Cyprus, 2011s
  70. Vandekerckhove L. P. R. , Wensing A. M. J. , Kaiser R., Brun-Vézinet F., Clotet B., De Luca A., Dressler S., Garcia F., Geretti A. M., Klimkait T., Korn K., Masquelier B., Perno C. F., Schapiro J. M., Soriano V., Sönnerborg A. M., Vandamme A. M., Verhofstede C., Walter H., Zazzi M. andBoucher C. A. B. on behalf of the European Consensus Group on Clinical Management of Tropism Testing. Consensus Statement of the European Guidelines on Clinical Management of HIV-1 Tropism Testing vs 1.0. Tenth International Congress on Drug Therapy in HIV Infection. Glasgow, UK, 2010
  71. Demetriou V. L., van de Vijver D. A. M. C., Kousiappa I., Balotta C., Clotet B., Grossman Z., Jørgensen L. B., Lepej S. Z., Levy I., Nielsen C., Paraskevis D., Poljak M., Roman F., Ruiz L., Schmidt J. C., Vandamme A. M., Vercauteren J. and Kostrikis L. G. Quantification of M-group HIV-1 Cellular DNA Load in Newly-Diagnosed Treatment-Naïve Patients in Europe: Lack of Correlation with Transmitted Resistance to Antiretroviral Drugs. XVIII International AIDS Conference. Vienna, Austria, 2010
  72. Hadjinicolaou A., Demetriou V. and Kostrikis L. G. Molecular Beacon Probes: A New Tool for Fast and Accurate Detection of Infectious Agents. 17th International Student Congress of Medical Sciences, Grotigen, Netherlands, 20103
  73. Demetriou V. L., Kousiappa I. and Kostrikis L. G. Molecular Epidemiology of HIV and HCV in Co-Infected Individuals in Cyprus. 6th Internationals Workshop on HIV and Hepatitis Co-Infection. Tel Aviv, Israel, 2010
  74. Demetriou V. L., Loizidou E. Z. and Kostrikis L. G. Implications of HCV Natural Genetic Diversity on HCV NS5B Nucleoside Inhibitor NM283. 8th European HIV Drug Resistance Workshop. Sorrento, Italy, 2010
  75. Demetriou V. L., van de Vijver D. A. and Kostrikis L. G. Molecular Characterization of HCV Strains from Cypriot IV Drug Users Reveals Multiple Introductions and Epidemiologically Related Transmission-Clusters. 8th European HIV Drug Resistance Workshop. Sorrento, Italy, 2010
  76. Demetriou V., and Kostrikis L. G. Implications of HCV Natural Genetic Diversity on HCV NS5B Inhibitor NM283. 16th International Symposium on HIV and Emerging Infectious Diseases. Marseille, France, 2010
  77. Loizidou E., and Kostrikis L. G. HIV-1 Integrase Inhibitors: Role of Natural Diversity on Drug Efficacy and Resistance. 2nd International Conference on Drug Discovery and Therapy. Dubai, United Arab Emirates, 2010
  78. Loizidou E., Kousiappa I., Zeinalipour-Yazdi C., Christophides T., Van de Vijver D. and Kostrikis L. G. Computational Analysis of the Binding Parameters of HIV-1 Intergrase Inhibitors and Correlation to Resistance Development. 12th European AIDS Conference. Cologne, Germany, 2009
  79. Demetriou V. L., van de Vijver D. A., Hezka J., Georgiades N., Savvopoulou N., Charilaou C. C., Argyriou A., Pavlou T., Platritis K., Veresies K. L., and Kostrikis L. G. Molecular Epidemiology of Hepatitis C Infection among Intravenous Drug Users Seeking Therapy in Cyprus. 16th International Symposium on Hepatitis C Virus and Related Viruses. Nice, France, 2009
  80. van de Vijver A. M. C., Wensing A. M. J., Vercauteren J., Albert J., Balotta C., Hamouda O., Kücherer C., Struck D., Schmit J. C., Asjo B., Bruckova M., Camacho R., Clotet B., Coughlan S., Grossman Z., Horban A., Korn K., Kostrikis L. G., Nielsen C., Paraskevis D., Poljak M., Puchhammer-Stockl E., Riva C., Ruiz L., Salminen M., Schuurman R., Sonnerborg A., Stanekova D., Stanojevic M., and Boucher C. A. B. on behalf of the SPREAD-Programme. Phylogenetic Analysis of Viral Sequences among Patients Newly Diagnosed with HIV across Europe Indicates that Most Infections Occur within Single Countries. 5th IAS, Cape Town, South Africa, 2009
  81. Kousiappa I., Van de Vijver D., and Kostrikis L. G. Near-Full Genetic Analysis of HIV-1 Sequences Derived from Cyprus: Evidence of a High Polyphyletic and Evolving Infection. 7th European HIV Drug Resistance Workshop, Stockholm, Sweden, 2009
  82. Loizidou E., Zeinalipour-Yazdi C., Van de Vijver D., and Kostrikis L. G. Structure-Based Computational Analysis of the Implications of Subtype Specific Polymorphisms on the Efficacy of Integrase Inhibitors. 7th European HIV Drug Resistance Workshop, Stockholm, Sweden, 20094
  83. Demetriou V. and Kostrikis G. Quantitation of HV-1 Cellular DNA Viral Load in Newly Diagnosed Drug Naïve Patients in Europe. 7th EuropeHIVResistance (EHR) Meeting, Utrecht, Netherlands, 2008 (Oral presentation)
  84. Loizidou E., Dikaiakos M., Nicolaides A., Nicolaou C., Pattichis C., Promponas V. and Kostrikis G. Drug Development for Non-B HIV-1 Strains. XVII International AIDS Conference, Mexico City, Mexico, 2008
  85. Loizidou E. Z., Kousiappa I., Themistokleous G., Zeinalipour-Yazdi C. D. and Kostrikis L. G. Genetic Analysis of HIV-1 Integrase within Primary M Group Strains: In-Silico Structural Analysis of Subtype Specific Polymorphisms on Integrase Inhibitor Efficacy. XVII International HIV Drug Resistance Workshop: Basic Principles and Clinical Implications, Sitges, Spain, 2008
  86. Kousiappa I., Van de Vijver D., Demetriades I. and Kostrikis L. G. Molecular Epidemiology and Drug Resistance Genotypic Analysis of Strains from Patients Infected with Human Immunodeficiency Virus Type 1 (HIV-1) in Cyprus. 15th International Symposium on HIV and Emerging Infectious Diseases, Tulon, France, 2008.
  87. Abecasis A. B., Wensing M. J., Paraskevis D., Vercauteren J., van de Vijver D. A., Albert J., B Asjo6, Balotta C., Bruckova M., Camacho R., Coughlan S., Grossman Z., Hamouda O., Horban A., Korn K., Kostrikis L.G., Kücherer C., Nielsen C., Poljak M., Puchhammer-Stockl E., Riva C., Ruiz L., Salminen M., Schmit J. C., Schuurman R., Sonnerborg A, Stanekova D., Stanojevic M., Struck D., Boucher C. A. B. and Vandamme A. M., on behalf of the SPREAD-Programme. Quantitation of HIV-1 Cellular Viral Load Within HIV-1 Group M Strains: Implications of Cellular Viral Load and Resistance. 6th European HIV Resistance Workshop, Budapest, Hungary, 2008
  88. Kostrikis L. G. and Loizidou E. Z. De novo Design of HIV-1 Integrase Inhibitors. 1st International Conference on Drug Design and Discovery, Dubai, United Arab Emirates, 2008
  89. Demetriou V. L. and Kostrikis L. G. Quantitation of HIV-1 Cellular Viral Load Within HIV-1 Group M Strains: Implications of Cellular Viral Load and Resistance. 4th EuropeHIVResistance (EHR) Meeting, Zeist, Netherlands, 2007 (Oral Presentation)
  90. Kousiappa I. and Kostrikis L. G. Molecular Epidemiology and Drug Resistance in Cyprus 2003-2006. 4th EuropeHIVResistance (EHR) Meeting, Zeist, Netherlands, 2007 (Oral Presentation)
  91. Demetriou V. L., Vounou-Hadjigeorgiou E., Koliou-Mazeri M., Papakyriakou P., Petsas L., Potamitis G., Chemonides S. and Kostrikis G. L. Genetic Analysis of Hepatitis C Virus (HCV) from patients in Cyprus: Evidence of Genotypic Heterogeneity Including the Presence of Two Recombinant Strains. 27th Greek National Congress of Gastroenterology, Salonika, Greece, 2007
  92. Kousiappa I., Van de Vijver D., Gilliland S., Demetriades I. and Kostrikis L.G. Epidemiology and Genotypic Analysis of Drug Resistant Strains from Naïve Patients Infected with Human Immunodefiencincy Virus Type 1 (HIV-1) in Cyprus. 5th European HIV Drug Resistance Workshop, Cascais, Portugal, 2007
  93. Kousiappa I., Giantsiou-Kyriakou A., Yiakoumi E., Demetriou V., Kostrikis L.G. Genetic Analysis of the Env Gene of HIV Isolates from Patients in Cyprus from 1994 until 2005: Evidence of a Highly Evolving Epidemic. 12th International Bioinformatics Workshop on Virus Evolution and Molecular Epidemiology, Athens, Greece, 2006
  94. Demetriou V. L., The Cyprus Hepatitis C Network and Kostrikis L. G. Epidemiological Analysis of the Hepatitis C Virus Infection in Cyprus. 12th International Bioinformatics Workshop on Virus Evolution and Molecular Epidemiology, Athens, Greece, 2006
  95. Kostrikis L.G. Host and Viral Correlates of HIV-1 Transmission and Disease Progression. US National Institute of Health 2006 NIAID Research Conference, Opatija, Croatia, 2006
  96. Kousiappa I., Giantsiou-Kyriakou A., Yiakoumi E., Demetriou V., Kostrikis L.G. Genetic Analysis of the Env Gene of Human Immunodeficiency Virus Type 1 (HIV-1) Strains from Patients in Cyprus from 1994 until 2005: Evidence of a Highly Evolving Epidemic. 14th International Symposium on HIV and Emerging Infectious Diseases, Tulon, France, 2006
  97. Kostrikis L.G. Multi-Allelic Detection of the Severe Acute Respiratory Syndrome-Associated Coronavirus (SARS-CoV) Using ‘Sloppy’ Molecular Beacons: A ‘Molecular Shotgun’ Approach of Recognizing a Moving Genetic Target. 8th Hellenic Symposium of Virology, Thessalonica, Greece, 2006
  98. Kousiappa I., Giantsiou-Kyriakou A., Yiakoumi E., Kostrikis L.G. Γενετική Ανάλυση της Περιοχής C2-C5 του Γονιδίου Env από Στελέχη του ιού της ανθρώπινης ανοσοανεπάρκειας τύπου 1 (HIV1) σε Ασθενείς στην Κύπρο από το 1994 έως και το 2005. 8th Hellenic Symposium of Virology, Thessalonica, Greece, 2006
  99. Kostrikis L.G. Implications of Cellular HIV-1 DNA Load in Disease Progression and Efficacy of Antiretroviral Therapy. 2nd International Workshop on HIV Persistence During Therapy, Saint Martin, French West Indies, 2005
  100. Papantoniou C, Demetriades, Wensing A. M. J., van Rooijen W. J. M., Chu M. L. J. N., Kostrikis L.G. Genetic Analysis of HIV-1 Isolates from Drug-Naïve Patients in Cyprus: High Prevalence of HIV non-B Subtypes and Spread of Drug-Resistance. 3rd European HIV Drug Resistance Workshop, Athens, Greece, 2005
  101. G. Kostrikis. Multi-allelic Detection of the Severe Acute Respiratory Syndrome-associated Coronavirus Using ‘Sloppy’ Molecular Beacons: A ‘Molecular Shotgun’ Approach of Recognizing a Moving Target. 13th International Symposium on HIV & Emerging Infectious Diseases, Tulon, France, 2004
  102. G. Kostrikis. Impact of HIV-1 Cellular Viral Load on the Progression of HIV-1 Disease. 1st International Workshop on HIV Persistence during Therapy, Saint Martin, USVI, 2003
  103. Hatzakis A., Touloumi G., Pantazis N., Anastassopoulou C., Katsarou O., Karafoulidou A., Goedert J. J., Kostrikis L. G. Cellular HIV-1-DNA Load Predicts the Outcome of Highly Active Antiretroviral Therapy (HAART). 2nd IAS Conference on Pathogenesis and Treatment, Paris, France, 2003
  104. Kostrikis L. G. Rapid Molecular Identification of Pathogenic Agents: Detection of Bacillus anthracis (anthrax) Strains in Clinical Samples. 4th Biomedical Symposium, Limassol, Cyprus, 2003
  105. Kostrikis L. G., Touloumi G., Karanicolas R., Pantazis N., Anastassopoulou C., Karafoulidou A., Goedert J., Hatzakis A. Quantitation of HIV-1 DNA Forms with the Second Template Switch (HIV-1 STS DNA) in Peripheral Blood Predicts Disease Progression in HIV-1 Infection Independently of Plasma RNA Load. XIV International AIDS Conference, Barcelona, Spain, 2002. (Selected for oral presentation)
  106. Metzner J., Bonhoeffer S., Fischer M., Karanicolas R., Weber R., Hirschel B., Kostrikis L. G., Günthard H. F. Detection of Minor Populations of Drug-Resistant-Viruses in Patients Undergoing Structured Treatment Interruptions. XI International HIV Drug Resistance Workshop, Seville, Spain. Antiviral Therapy 7: S1, 2002. (Selected for oral presentation)
  107. Barboushe R., Hong L., Dellagi K., Kostrikis L. G. Contrasting Frequencies of 32-CCR5 and CCR2-V64I Alleles in the Tunisian Population. The 1ST IAS conference on HIV Pathogenesis and Treatment, Buenos Aires, Argentina, 2001
  108. Touloumi G., Karanicolas R., Pantazis , Karafoulidou A., Mandalaki T., Goedert J. J., Kostrikis L. G., Hatzakis A. Analysis of Longitudinal T-cell Excision DNA Levels in HIV-1 Infected Subjects pre- and post-HAART. The 8th European Conference on Clinical Aspects and Treatment of HIV-Infection, Athens, Greece, 2001
  109. Gao F., Li Y., Trask S., Chen Y., Kostrikis L. G., Ho D. D., Oh M., Vidal N., Shaw G., Hahn B., Peeters M. Evidence for Distinct Sub-subtypes within HIV-1 Subtype A. The 8th Conference on Retroviruses and Opportunistic Infections, Chicago, USA, 2001
  110. Kramer T., Touloumi G., Karanicolas R., Pappa M., Pollack H., Palumbo P., Kostrikis L. G. Effect of Recent Thymic Emigrants on Progression of HIV-1 Disease Among Children with Perinatal HIV-1 Infection. The 8th Conference on Retroviruses and Opportunistic Infections, Chicago, USA, 2001. (Selected for oral presentation)
  111. Valentin A., Rosati , Patenaude D., Yarchoan R., Kostrikis L. G., A. Hatzakis A., and Pavlakis G. N. Natural Killer Cells Are Targets for HIV-1 Infection in Vivo: Use of Real-Time PCR for the Quantification of Cell-Associated Viral Load. AIDS Vaccine 2001 Conference, Philadelphia, USA, 2001
  112. Metzner K. J., Moretto W. J., Gettie A., Binley J. M., Ho D. D., Marx P. A., Kostrikis L. G., Nixon D. F., Connor R. I. Impact of in vivo CD8+ T Cell Depletion on Rechallenge with Pathogenic SIV in Rhesus Macaques Immunized with a Live, Attenuated SIV Vaccine. 18th Annual Symposium on Nonhuman Primate Models for AIDS, Wisconsin, USA, 2000
  113. Gao F., Li Y., Trask S. A., Chen Y., Kostrikis G., Ho D. D., Oh M., Peeters M., Hahn B. H. New Genetic Variants of HIV-1. US-Japan cooperative medical science program Twelfth joint scientific meeting of the AIDS Panel Santa Fe, New Mexico, 2000
  114. Sharkey M., Teo I., Greenough T., Sharova N., Luzuriaga K., Sullivan J. L., Bucy P., Kostrikis L. G., Davaro R., Cheeseman S., Daly J., Bova C., Ellison D., Mady B., Lai K. K., Moyle G., Nelson M., Gazzard B., Stevenson M. Persistence of Episomal HIV-1 Infection Intermediates in the Face of HAART and Sustained, Undetectable HIV-1 RNA. The 7th Conference on Retroviruses and Opportunistic Infections, San Fransisco, USA, 2000
  115. Metzner K., Jin X., Lee F., Gettie A., Daily P., Ho D. D., Marx P., Kostrikis L. G., Connor R. Effects on in vivo CD8-Depletion on the Control of Virus Replication in Rhesus macaques Immunized with a Live, Attenuated SIV Vaccine and Protected from Pathogenic SIV. The 7th Conference on Retroviruses and Opportunistic Infections, San Francisco, USA, 2000
  116. Hatzakis A., Touloumi G., Karafoulidou A., Mandalaki T., Karanicolas R., Anastassopoulou C., Zhang L., Goedert J. J., Ho D. D., Kostrikis L. G. Effect of Recent Thymic Emigrants on HIV-1 Disease Progression. The 7th Conference on Retroviruses and Opportunistic Infections, San Francisco, USA, 2000
  117. Metzner K., Jin X., Gettie A., Daily P., Ho D. D., Marx P., Kostrikis L. G., Connor R. Effects on in vivo CD8-Depletion on the Control of Virus Replication in Rhesus macaques Immunized with a Live, Attenuated SIV Vaccine and Protected from Pathogenic SIV. 17th Annual Symposium on Nonhuman Primate Models for AIDS, New Orleans, Louisiana, USA, 1999
  118. Kostrikis L. G., Neuman A. U., Thompson B., Lew J. F., McIntosh K, Pollack H., Palumbo P., Ho D. D., Moore J. P. Polymorphisms in the Regulatory Region of the CCR5 Infuence Perinatal Transmission of HIV. Teratology Society: HIV Infection During Pregnancy, Keystone, Colorado, USA, 1999
  119. Lewin S., Zhang, L., Kostrikis L.G., Karanicolas R., Skulsky E., Vesamen M., Hurley A., Ramratnam B., Kost R., Markowitz M., Ho D.D. The Impact of HIV Infection on the Number of Recent Thymic Emigrants in Blood and the Effect of HAART. The 6th Conference on Retroviruses and Opportunistic Infections, Chicago, USA, 1999
  120. Zhang, L., Lewin S., He Y., Lin H., Tuttleton S., Skulsky E., Karanicolas R., Spiegel H., Borkowsky W., Kostrikis L.G., Ho D.D. Quantifying Recent Thymic Emigrants (RTE) in Blood of >400 Normal Persons with a Real-Time PCR/Molecular Beacon Assay for T-Cell Receptor (TCR) Excisional Circles (TREC).The 6th Conference on Retroviruses and Opportunistic Infections, Chicago, USA, 1999
  121. Paxton W., Neumann A., Brown C., Deutsch L., Kang S., Kostrikis L. G., Ho D. D., Koup R., Wolinsky S. High RANTES Production from CD4+ Cells Correlates with Slower Progression to AIDS and with CCR5-Δ32 Heterozygosity. The 6th Conference on Retroviruses and Opportunistic Infections, Chicago, USA, 1999
  122. Lewin S., Vesamen M., Kostrikis L. G., Zhang L., Ho D. D., Markowitz M. The Use of Real-Time PCR to Quantify HIV Unspliced (US) mRNA in Patients on Effective Antiretroviral Therapy. The 6th Conference on Retroviruses and Opportunistic Infections, Chicago, USA, 1999
  123. Kostrikis L. G., Martinson J. R. Global Distribution of the CCR2-64I/CCR5-59653-T HIV Disease-Protective Haplotype. The 6th Conference on Retroviruses and Opportunistic Infections, Chicago, USA, 1999
  124. Kostrikis L. G., Neuman A. U., Thompson B., Lew J. F., McIntosh K, Pollack H., Palumbo P., Ho D. D., Moore J. P. Polymorphisms in the Regulatory Region of the CCR5 Influence Perinatal Transmission of HIV. The 6th Conference on Retroviruses and Opportunistic Infections, Chicago, USA, 1999. (Selected for oral presentation)
  125. Kostrikis L. G., Huang Y., Neumann A. U., Moore J. P., Ho D. D. Molecular Beacon-Based Real-time PCR for Automated Detection of Point Mutations in Human Alleles: The Implications of Polymorphisms in the Regulatory Region of the CCR5 in HIV-1 Transmission and Pathogenesis. Keystone Symposia: HIV Pathogenesis and Treatment, Park City, Utah, USA, 1998
  126. Robbins K. E., Kostrikis L.G., Brown T. M., Anzala O., Shin S., Plummer F. A., Ho D. D., Kalish M. L. Changing Human Immunodeficiency Virus Type 1 Subtypes in Kenya as Determined by DNA sequencing and the Combinatorial Melting Assay (COMA). Keystone Symposia: HIV Pathogenesis and Treatment, Park City, Utah, USA, 1998
  127. Kostrikis L. G., Ho D. D., Moore J. P. The Effect of Polymorphisms in the Regulatory Regions of the CCR5 Promoter on HIV-1 Vertical Transmission and on Disease Progression in Infected Children. Keystone Symposia: HIV Pathogenesis and Treatment, Park City, Utah, USA, 1998
  128. Gao F., Robertson D. L., Carruthers C. D., Li Y., Kostrikis L. G., Ho D. D., Hahn B. H. Evidence for Quadruple Recombination Between Subtypes A, C, G, and I in an HIV-1 Isolate from Cyprus. The 5th Conference on Retroviruses and Opportunistic Infections, Chicago, USA, 1998
  129. Moore J. P., Kostrikis L. G., Ho D. D. The Effect of Polymorphisms in the Regulatory Regions of the CCR5 Promoter on HIV-1 Vertical Transmission and on Disease Progression in Infected Children. Conference on Retroviruses and Opportunistic Infections, Chicago, USA, 1998
  130. Kostrikis L. G., Shin S., Ho D. D. Genetic Homologies of HIV-1 and HCV Strains Determined with Differential Melting of Combinatorial DNA Arrays. The 5th Conference on Retroviruses and Opportunistic Infections, Chicago, USA, 1998
  131. Kostrikis L. G. and Ho D. D. Implications of Genetic Variation of Human Immunodeficiency Virus Type 1 in Vaccine Development. The 4th World Biomedical Conference of the Hellenic Diaspora, Nicosia, Cyprus, 1996
  132. Kostrikis L.G., Bagdades E., Dimitriou D., Ho D. D. Molecular Epidemiology of HIV-1 Infection in Cyprus: Identification of a New subtype (I). The First National Symposium on AIDS and Sexually Transmitted Diseases, Thessaloniki, Greece, 1996
  133. Kostrikis L. G., Cao Y., Ngai H., Moore P., Bradac J. and Ho D. D. Lack of  Direct Correlation between Neutralization Serotypes and Genetic Subtypes of HIV-1. Keystone Symposia: Prevention and Treatment of AIDS, Hilton Head Island, USA, 1996
  134. Bradac J., Cao Y., Leu J., Qin L., Ngai H., Kostrikis L. G., Moore J. P., Ho D. D. Inter- and Intra- Subtype Neutralization of Human Immunodeficiency Virus Type 1: Implications for Vaccine Development. The Tenth Cent-Gardes Symposium on Retroviruses of Human AIDS and Related Human Diseases, Marnes-La-Coquette, France, 1995
  135. Kostrikis L. G., Bagdades E., Cao Y., Zhang L., Dimitriou D., Ho D. D. Genetic Analysis of Human Immunodeficiency Virus Type-1 from Patients in Cyprus: Identification of a New Subtype (I). Keystone Symposia: HIV Pathogenesis, Keystone, CO. Cell. Biochem. 19D, 430, 1995
  136. Kostrikis L. G., Ho D. D. Immunity to HIV-1 Antigens Displayed on the Surface of   Keystone Symposia: Prevention and Treatment of AIDS, Hilton Head Island, SC. J. Cell. Biochem. 18B, 157, 1994
  137. Kostrikis L. G., Liu D. J., Day L. A. Hyperchromicity of DNA and Tyrosines in Pf1 Filamentous Virus. Biophysical Society Meeting (U.S), Washington, D.C. J. 64 (2), 189, 1993
  138. Day L. A., Kostrikis L. G., Kim H.-Y., Marzec C. J. Structure Variability of Filamentous Bacterial Viruses. 15th International Congress of Biochemistry. Jerusalem, Israel, 1991
  139. Kostrikis L. G., Reisberg S. A., Day L. A. Transfection of coli by Pf1 Viral RF-DNA produces Epf1, a Virus with a Structure Like Pf1 that Infects Pseudomonas aeruginosa. Biophysical Society Meeting (U.S), San Francisco, CA. Biophys. J. 59, 2831, 1991